Auchincloss has pledged a root-and-branch overhaul of BP’s strategy. The company is in crisis after it revealed profits slumped by a third last year.Read More
You might also be interested in reading AbbVie raises 2025 revenue outlook to $60.5B as Skyrizi and Rinvoq drive growth.
